This week Steve welcomes fellow Oxford alum, Talia Cohen Solal, CEO and Co-Founder of Genetika+, the company using tech to tailor depression treatment. Talia Cohen Solal, Ph.D., CEO and Co-founder:

During her 10-year academic career across Oxford, UCL and Columbia University, Talia led the development neural models of mental illnesses and drug development platforms for unique/personalized forms of diseases